Investable indexes: July 2012 returns

Hedge fund strategies performed mostly positively during July. CTAs were one of the strongest performers, benefiting from the US drought and rising energy prices. Only a few strategies had declines.

drought-australia

Dow Jones/Credit Suisse
The Dow Jones Credit Suisse Hedge Funds Index ended July up 1.42% and only two of the 10 sub-strategies had losses for the month. Dedicated short bias was the worst performer for the month, ending down 0.44%. However, this is an improvement on its June performance when it ended the month down 2.72%. Equity market neutral was close behind dedicated short bias, dropping 0.4% in July. Managed futures outperformed the other sub-strategies by some distance, gaining 4.68%. This is a reversal of June’s performance when the strategy was down 3.56%. Global macro performed second best in July, gaining 2.14%. Fixed income arbitrage also had a positive performance in July, ending the month up 1.62%. Long/short equity and convertible arbitrage had marginally positive performances, rising 0.55% and 0.86% respectively.dowjones0912
FrontEdge Global Hedge Fund
The FrontEdge Global Hedge Fund returned 1.23% in July 2012 compared with 0.73% for the benchmark HFRI Fund of Funds Index. All of the six underlying hedge fund sub-strategies were positive in July.
The best-performing strategy was managed futures, up 4.23%, followed by convertible and volatility arbitrage and equity long/short, returning 1.42% and 1.16% respectively. The synthetic replication blend returned 0.41%. Over the past 12 months, the fund has returned a negative 2.47% with volatility of 3.99% compared with a 12-month return of -4.28% and volatility of 5.23% for the HFRI Fund of Funds index.
The fund combines investments in around 40 single hedge fund managers with a significant allocation to a blend of synthetic replication products.frontedge0912
HFRX
The HFRX Global Hedge Fund Index was up 0.54% in July, with all but two sub-strategies ending the month in positive territory. As the impact of the drought in the US continued and energy prices rose, managers captured consistent trends in commodity positions in agriculturals and energy. The Macro Systematic Diversified CTA Index gained 3.23% for the month and the Equity Hedge Index posted a gain of 0.55%. The Equity Market Neutral Index posted a modest decline of 0.07% as positive contributions from factor-based models were offset by declines in behavioural strategies. The Event Driven Index posted a gain of 0.25% for the month with contributions from distressed/restructuring, activist and equity special situation strategies. The Distressed Index posted a gain of 0.45%, bringing year-to-date performance to 3.50%. The Merger Arbitrage Index declined 0.20% in July, with mixed performance across core positions.hfrx0912
Lyxor
The Lyxor Hedge Fund Index gained 1.05% in July and 12 strategy indexes out of 14 ended the month in positive territory, led by the Lyxor Long Term CTA Index (up 3.2%) and Lyxor Long/Short Equity Statistical Arbitrage Index (up 2.1%).
CTAs focused on medium and long-term trends finished the month with a 3.2% gain. Statistical arbitrage and equity market neutral managers posted gains of 2.1% and 1.8%, respectively.
Long/short credit funds gained 0.8% and convertible arbitrage managers gained 1.1%. Fixed income arbitrage specialists gained 0.2% to boost YTD performance to 5.9%. Merger arbitrage managers were down slightly in July as some extremely tight spreads widened. The Lyxor Merger Arbitrage Index declined 0.3%.
Special situations managers gained 0.3%, with losses in gold mining stocks seriously denting the performance of some funds.
Distressed managers declined 0.2% in July. Long bias managers gained 1.2% while variable bias managers were flat on the month. The Long Bias Index performance for the year now stands at 5.6%.lyxor0912

 

 

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here